Pitango Venture Capital, one of the largest venture capital firms in Israel, announced the first closing of a new $175 million healthcare technology fund. With the new fund, the firm plans to build a portfolio of approximately 15 new companies over a period of three to four years.

UltraSight, based in Israel, recently received a nod from the FDA to market its UltraSight AI Guidance product that can assist medical professionals without sonography experience in acquiring cardiac ultrasound images and allow for more widespread detection of heart diseases.

Israeli health tech fund Shoni Health Ventures recently launched to invest in digital health and medical device startups that are in the pre-seed and seed stages of fundraising. The fund is affiliated with Sheba Medical Center, the largest hospital in Israel. Startups will have access to the hospital’s innovation center so that they can develop, pilot and commercialize their products.

NeuraLight just raised $25 million in its bid to create new, digital endpoints that can be used by clinicians and researchers to objectively measure neurological conditions with the ultimate goal – still several years away – to have the company’s technology serve as the gold standard for neurological evaluation.

A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.

The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.

A new telehealth company, called Antidote, is taking aim at rising healthcare costs in the U.S. by providing an alternative inspired by the healthcare system in Israel. For a monthly membership fee, Antidote users gain unlimited virtual visits and zero copays on most medications.

Tel Aviv-based Ibex Medical Analytics published data on what it called the first algorithm to go beyond detection and into areas like tumor grading and sizing.

The company, based near Tel Aviv, said it plans to invest money from the fund, Arkin Bio-Ventures II, in areas like gene therapy, as well as RNA- and DNA-targeted drugs.

K Health, a startup that lets patients look up their symptoms and chat with a doctor, raised $48 million in funding.

With the regulatory nod, Sight Diagnostics can have its computer-vision powered blood analyzer be sold to hospital labs to provide lab-grade results within 10 minutes on just two drops of blood.

The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.

The Israeli maker of FDA-cleared medical devices announced it has expanded its partnership with Best Buy such that its connected device kit – TytoHome – is sold in the retailer’s U.S. locations.

89Bio, a biopharma company developing a drug to treat NASH, went public on Monday and saw its stock increase beyond the $16 per share it had opened with.

This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million. 

The Israeli company’s technology uses the power of focused ultrasound guided by MR imaging to target conditions like essential tremor, Parkinson’s disease and neuropathic pain.

Medial EarlySign is hoping to leverage the power of artificial intelligence to identify patients at high risk for certain diseases to bend overall cost curve and benefit patients.

Nerivio Migra consists of a bioelectric patch which is placed on the upper arm and an associated smartphone app which controls the electrical impulses and records data.

The FDA decision, which builds on a prior approval of the company’s algorithm for the detection of intracranial hemorrhages through CT scans, is part of a larger vision sketched out by CEO Elad Walach of plugging new algorithms into the Aidoc system to create a new standard of care in radiology.

The product, HealthPNX, automatically flags findings suggestive of pneumothorax based on chest X-rays or digital radiography scans and informs the medical team.

TytoCare’s TytoHome product will be offered online through BestBuy.com and brick-and-mortar stores in Minnesota. Availability is also coming soon to locations in California, North Dakota and South Dakota.

Avi Veidman was prompted to create the Tel Aviv-based company, Nucleai, after witnessing his father anxiously wait about 30 days to receive his biopsy results.

Here’s how providers at the Hospital Israelita Albert Einstein in Brazil take care of workers on an oil platform away from the continent.

The company raised a $33.5 million Series C round that included participation from rural healthcare system Sanford Health, Chinese insurer Ping An and global pharmacy chain Walgreens.

Healthy.io’s urinalysis testing kit – dubbed Dip.io – uses disposable strips and cups in conjunction with a smartphone camera to read and interpret results.

An Israeli startup, Accelerated Evolution Biosciences, or AEBi, claimed it has a “complete cure for cancer” on the way. A newspaper gave the company glowing coverage it didn’t deserve.

The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.

Earlier this year, the company, which raised $3.5 million in 2016, revealed the findings of a three-month study of its technology conducted at Johns Hopkins University.

The program from IBM Israel and Hadassah Medical Center, which will begin in the first quarter of 2019 and last six months, is open to startups that have completed a post-seed round of financing, according to Israeli publication Globes.

VRHealth is delivering its virtual reality solutions through Oculus Go and Rift to help patients manage their pain and alleviate their anxiety.